Tert-butyl 4-(1-(4-(methylsulfonyl)phenyl)-2-oxo-1,2-dihydropyridin-4-yloxy)piperidine-1-carboxylate → Isopropyl 4-((1-(4-(methylsulfonyl)phenyl)-2-oxo-1,2-dihydropyridin-4-yloxy)methyl)piperidine-1-carboxylate

Participants

Reaction Steps

Example 5 was prepared according to procedures described in Example 3 substituting tert-butyl 4-((1-(4-(methylsulfonyl)phenyl)-2-oxo-1,2-dihydropyridin-4-yloxy)methyl)piperidine-1-carboxylate for tert-butyl 4-(1-(4-(methylsulfonyl)phenyl)-2-oxo-1,2-dihydropyridin-4-yloxy)piperidine-1-carboxylate. 1H NMR (500 MHz, CDCl3) δ 8.07 (d, J=8.25 Hz, 2H), 7.61 (d, J=8.80 Hz, 2H), 7.23 (d, J=7.70 Hz, 1 H), 6.09 (dd, J=7.70, 2.75 Hz, 1H), 6.01 (d, J=2.75 Hz, 1H), 4.87-4.98 (m, 1H), 4.23 (app brs, 2H), 3.85 (d, J=6.05 Hz, 2H), 3.09 (s, 3H), 2.79 (t, J=2.65 Hz, 2H), 1.87-2.06 (m, 1H), 1.76-1.87 (d, J=12.10 Hz, 2H), 1.18-1.37 (m, 6H), 1.25 (d, J=6.05 Hz, 6H). MS (ESI) 449 (M+H).

Provenance & Evidence